IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Cosentini, Deborah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.238
AS - Asia 2.760
EU - Europa 2.192
SA - Sud America 445
AF - Africa 60
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.700
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.122
SG - Singapore 1.055
CN - Cina 667
IT - Italia 583
BR - Brasile 356
PL - Polonia 347
FI - Finlandia 260
HK - Hong Kong 257
DE - Germania 242
VN - Vietnam 219
BD - Bangladesh 204
GB - Regno Unito 116
UA - Ucraina 111
FR - Francia 110
TR - Turchia 89
RU - Federazione Russa 86
IE - Irlanda 82
IN - India 76
CA - Canada 72
SE - Svezia 51
ID - Indonesia 41
CZ - Repubblica Ceca 40
AR - Argentina 38
JP - Giappone 36
NL - Olanda 35
ES - Italia 31
MX - Messico 27
BE - Belgio 26
ZA - Sudafrica 23
IQ - Iraq 21
AT - Austria 16
CH - Svizzera 12
EC - Ecuador 12
PK - Pakistan 12
CL - Cile 11
SA - Arabia Saudita 10
LT - Lituania 9
MA - Marocco 9
PT - Portogallo 9
UZ - Uzbekistan 9
DZ - Algeria 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
JO - Giordania 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CO - Colombia 5
CR - Costa Rica 5
JM - Giamaica 5
KE - Kenya 5
LB - Libano 5
PY - Paraguay 5
EG - Egitto 4
ET - Etiopia 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
TW - Taiwan 4
AU - Australia 3
GY - Guiana 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
OM - Oman 3
BO - Bolivia 2
EE - Estonia 2
IL - Israele 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 10.700
Salva come PNG Salva come JPEG
Città #
Singapore 544
Ashburn 503
Dallas 386
San Jose 356
Warsaw 341
Fairfield 275
Hong Kong 256
Chicago 244
Los Angeles 204
New York 196
Helsinki 191
Chandler 157
Beijing 154
Seattle 125
Houston 116
The Dalles 116
Woodbridge 111
Salt Lake City 101
Wilmington 98
Munich 92
Council Bluffs 89
Cambridge 79
Jacksonville 79
Brescia 76
Buffalo 69
Istanbul 69
Princeton 69
Milan 62
Ho Chi Minh City 61
Lauterbourg 61
Secaucus 60
Tampa 51
Dublin 48
Turku 48
Elk Grove Village 47
Boardman 44
Santa Clara 44
Ann Arbor 43
Shanghai 43
Moscow 42
Hanoi 40
Redondo Beach 38
Jakarta 37
Rome 37
Dalmine 36
Brno 32
Orem 32
West Jordan 30
Des Moines 28
Dong Ket 28
Sterling 27
São Paulo 27
Bergamo 26
Brussels 26
London 25
San Francisco 25
Montreal 23
Naples 23
Menlo Park 22
Phoenix 21
Brooklyn 20
Dearborn 20
Lancaster 20
Poplar 20
Romola 20
Stockholm 20
Atlanta 18
Nuremberg 18
Rio de Janeiro 18
Chennai 17
Frankfurt am Main 17
Johannesburg 17
Lappeenranta 17
Nanjing 17
Tokyo 17
Mumbai 16
San Diego 15
Toronto 15
Boston 14
Denver 14
Dulles 14
Pune 14
Haiphong 13
Amsterdam 12
Miami 12
Washington 12
Charlotte 11
Guangzhou 11
Tianjin 11
Biên Hòa 10
Detroit 10
New Delhi 10
Paris 10
Ankara 9
Changsha 9
Da Nang 9
Gumyojicho 9
Kansas City 9
Kyiv 9
Las Vegas 9
Totale 6.896
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 790
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 381
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 256
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 253
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 250
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 248
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 228
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Immunotherapy failure in adrenocortical cancer: where next? 223
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 202
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 199
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 190
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 189
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 189
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 184
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 182
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 173
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 165
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 153
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 148
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 148
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 145
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 137
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 136
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 135
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 132
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 132
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 127
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 127
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 126
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 125
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 125
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 123
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 119
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 118
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 118
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 117
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 116
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 116
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 114
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 112
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 110
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 110
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 108
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 106
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 106
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 105
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 102
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 100
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 100
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 98
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 98
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 94
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 93
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 93
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 91
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 90
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 87
Adjuvant denosumab for early breast cancer-Evidence and controversy 86
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 85
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 84
The Evolving Treatment Landscape of Medullary Thyroid Cancer 83
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 82
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 82
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 80
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 75
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 71
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 70
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 69
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 59
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 59
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 56
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 52
null 51
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 50
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 49
Oligometastatic adrenocortical carcinoma: definition and treatment 49
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 40
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 38
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 37
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 31
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 25
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 22
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 21
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 19
Primary Adrenal Malignancies 12
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study 8
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 5
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 5
Updating ACC preclinical models: characterization of two new patient-derived cell lines 5
Totale 10.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/2022398 37 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024918 43 31 74 75 74 171 27 50 129 61 23 160
2024/20252.833 54 45 30 414 174 131 154 88 293 122 675 653
2025/20264.688 343 507 570 484 392 331 562 191 326 441 300 241
Totale 10.875